相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Texaphyrins: Tumor Localizing Redox Active Expanded Porphyrins
Jonathan F. Arambula et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53
Michelle Martinez-Rivera et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin-platinum conjugate
Jonathan F. Arambula et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog
Guangan He et al.
GYNECOLOGIC ONCOLOGY (2011)
Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: Synthesis and comparison with carboplatin in normal and Pt-resistant cell lines
Jonathan F. Arambula et al.
DALTON TRANSACTIONS (2009)
Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads
Shanta Dhar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature
Sumitra Mukhopadhyay et al.
BIOCONJUGATE CHEMISTRY (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Wild-type p53: Tumors can't stand it
Michael B. Kastan
CELL (2007)
Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue
Markus Galanski et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity
S van Zutphen et al.
COORDINATION CHEMISTRY REVIEWS (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes
KR Barnes et al.
CHEMISTRY & BIOLOGY (2004)
Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues
O Aronov et al.
BIOCONJUGATE CHEMISTRY (2004)
Distribution and subcellular localization of a water-soluble hematoporphyrin-platinum(II) complex in human bladder cancer cells
C Lottner et al.
CANCER LETTERS (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies
O Aronov et al.
BIOCONJUGATE CHEMISTRY (2003)
Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents
K Mujoo et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
分享论文
